Geode Capital Management
ONCY

Geode Capital Management’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Geode Capital Management’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-44,017
Closed -$20K – 4199
2015
Q3 		$20K Buy
44,017
+1,656
+4% +$948 ﹤0.01% 4089
2015
Q2 		$20K Buy
42,361
+20,828
+97% +$14.1K ﹤0.01% 3937
2015
Q1 		$15K Buy
21,533
+9,643
+81% +$6.19K ﹤0.01% 3934
2014
Q4 		$6K Buy
11,890
+414
+4% +$250 ﹤0.01% 3974
2014
Q3 		$6K Buy
11,476
+276
+2% +$349 ﹤0.01% 3914
2014
Q2 		$14K Sell
11,200
-138
-1% -$198 ﹤0.01% 3834
2014
Q1 		$20K Buy
11,338
+414
+4% +$699 ﹤0.01% 3804
2013
Q4 		$17K Buy
10,924
+276
+3% +$622 ﹤0.01% 3751
2013
Q3 		$26K Buy
10,648
+276
+3% +$764 ﹤0.01% 3629
2013
Q2 		$30K Buy
+10,372
New +$28.7K ﹤0.01% 3568

Other funds holding ONCY

NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
KWMG
King Wealth Management Group Naples, Florida $914M AUM 24.3% 1-Year Est. Return
CS
Credential Securities Vancouver $440M AUM 9.75% 1-Year Est. Return

Geode Capital Management's ONCY Position: Q4 2015 in Review

Geode Capital Management sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2015, closing a stake of 44,017 shares — an estimated $20K sold.

Geode Capital Management first reported a position in ONCY in Q2 2013 and held it in 10 quarters. The position peaked at $30K in Q2 2013. 7 funds tracked by Wall St. Rank hold ONCY as of Q4 2015.

  • Geode Capital Management reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2015 after selling out during the quarter.
  • Geode Capital Management sold 44,017 ONCOLYTICS BIOTECH INC shares in Q4 2015, an estimated $20K.
  • Geode Capital Management first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 10 quarters.
  • Geode Capital Management's ONCOLYTICS BIOTECH INC position peaked at $30K in Q2 2013.
  • 7 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2015.

Based on Geode Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.